Andrew Paul Mazar
CIK: 0001727393
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACTUATE THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 1, 2026ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
105K shares- - Apr 1, 2025ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
51K shares- - Apr 1, 2025ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
110.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 105,000 | - | - | Direct |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 51,046 | - | - | Direct |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 110,346 | - | - | Direct |
1-3 of 3 transactions
About Mazar Andrew Paul
Mazar Andrew Paul (SEC CIK 0001727393) files insider reports with the SEC as Chief Operating Officer of ACTUATE THERAPEUTICS, INC. (ACTU).
Signal8 holds 2 ownership filings by Mazar Andrew Paul, all Form 4s, filed between Apr 2, 2025 and Apr 1, 2026. Those filings report 3 transactions, from Apr 1, 2025 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mazar Andrew Paul's filings is in FORT WORTH, TX.
Recent filings by Mazar Andrew Paul
Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)
- THOMSON TODD S, Director
- BIOS Fund III, LP, Director
- BIOS Fund I, LP, Director
- SCHMITT DANIEL M, President, CEO and Director
- Zabrowski Dan, Director
- Sawhney Roger, Director